| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |